Genomma Lab Internacional, S.A.B. de C.V. Stock
Stocks
LAB B
MX01LA010006
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.61 MXN | -1.48% |
|
-4.70% | -18.33% |
| Market Cap | 14.28B 830M 717M 661M 618M 1.15B 78.92B 1.18B 7.83B 3.04B 38.36B 3.11B 3.05B 133B | P/E Ratio 2026 * |
6.32x | P/E Ratio 2027 * | 6.58x |
|---|---|---|---|---|---|
| Enterprise Value | 17.98B 1.05B 903M 832M 779M 1.45B 99.39B 1.48B 9.87B 3.83B 48.31B 3.92B 3.84B 167B | EV / Sales 2026 * |
0.98x | EV / Sales 2027 * | 0.92x |
| Free-Float |
69.07% | Yield 2026 * |
5.48% | Yield 2027 * | 7.51% |
Last Transcript: Genomma Lab Internacional, S.A.B. de C.V.
| 1 day | -1.48% | ||
| 1 week | -4.70% | ||
| Current month | -8.57% | ||
| 1 month | -13.29% | ||
| 3 months | -17.92% | ||
| 6 months | -22.16% | ||
| Current year | -18.33% |
| 1 week | 14.58 |  | 15.34 |
| 1 month | 14.58 | | 16.8 |
| Current year | 14.58 | | 19.48 |
| 1 year | 14.58 | | 23.6 |
| 3 years | 12.39 | | 29.18 |
| 5 years | 12.39 | | 29.18 |
| 10 years | 11.1 | | 29.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | 12/04/2023 |
| Director of Finance/CFO | - | 01/12/2015 | |
| Investor Relations Contact | - | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/10/1996 | |
Juan Alonso
BRD | Director/Board Member | - | 06/07/2010 |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.48% | -4.70% | -32.98% | -0.20% | 832M | |
| -2.41% | +0.69% | +40.12% | +154.01% | 1,035B | |
| +1.07% | +5.57% | +55.14% | +50.53% | 574B | |
| +1.32% | +1.24% | +18.92% | +64.81% | 397B | |
| +0.77% | +0.77% | +21.19% | +15.95% | 324B | |
| -0.85% | -0.68% | +23.44% | +14.94% | 281B | |
| +0.44% | +5.39% | +25.86% | +35.39% | 278B | |
| +1.66% | +1.20% | -44.41% | -47.37% | 193B | |
| +0.32% | +2.78% | +21.72% | +62.37% | 191B | |
| -0.22% | -2.78% | +14.90% | +60.77% | 156B | |
| Average | +0.00% | +1.30% | +14.39% | +41.12% | 343.08B | |
| Weighted average by Cap. | +0.15% | +2.39% | +28.92% | +71.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.32B 1.06B 920M 848M 794M 1.48B 101B 1.51B 10.05B 3.9B 49.23B 4B 3.91B 171B | 19.24B 1.12B 966M 891M 833M 1.55B 106B 1.59B 10.55B 4.1B 51.69B 4.2B 4.11B 179B |
| Net income | 2.14B 124M 107M 98.91M 92.55M 173M 11.81B 176M 1.17B 455M 5.74B 466M 456M 19.89B | 2.25B 131M 113M 104M 97.49M 182M 12.44B 186M 1.23B 479M 6.05B 491M 480M 20.96B |
| Net Debt | 3.7B 215M 186M 171M 160M 299M 20.47B 306M 2.03B 789M 9.95B 808M 790M 34.48B | 3.44B 200M 173M 159M 149M 278M 19.01B 284M 1.89B 733M 9.24B 750M 734M 32.02B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/06/26 | 14.61 $ | -1.48% | 3,627,110 |
| 11/06/26 | 14.83 $ | +0.34% | 3,647,872 |
| 10/06/26 | 14.78 $ | -2.12% | 3,712,730 |
| 09/06/26 | 15.10 $ | +1.14% | 3,854,865 |
| 08/06/26 | 14.93 $ | +1.50% | 4,215,708 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LAB B Stock
Select your edition
All financial news and data tailored to specific country editions
